Trials / Terminated
TerminatedNCT01502748
Endovascular Magnesium Sampling in Acute Stroke
Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Southern California · Academic / Other
- Sex
- All
- Age
- 40 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
This investigation will address the safety and feasibility of distal, intra-arterial sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be measured in the region of infarct in patients who had been treated with intravenous Magnesium therapy following an acute stroke. This study attempts to address whether the traditional intravenous means of neuroprotectant administration achieves adequate concentration of the therapeutic agent in the area of diseased tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | endovascular sampling | Paired sampling from the distal arterial(endovascular catheter) and peripheral venous (femoral sheath) locations: withdrawal of 3ml of blood from vasculature distal to the occlusive thrombus |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-01-02
- Last updated
- 2017-08-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01502748. Inclusion in this directory is not an endorsement.